Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

Public

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

N

Shared by NobleBlocks on Oct 5, 2006 • 12:00 AM UTC

Authors:

David M. Brown

,

Peter K. Kaiser

,

Mark Michels

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Oct 5, 2006 • 12:00 AM UTC

NobleID:w1/20260526/B8353356

DOI:10.1056/nejmoa062655

No figures available

Generate Podcast

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration | NobleBlocks